Low dose topiramate/phentermine composition and methods of use thereof
US9011905B2 · kind B2 · utility
0Cited by
39References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 2014 |
| Grant date | Apr 21, 2015 |
| Priority date | — |
| Expiry date | Sep 24, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for effecting weight loss by administering a combination of topiramate and phentermine is provided. The phentermine is generally administered in immediate release form, in a daily dose in the range of 2 mg to 8 mg, in combination with a daily dose of topiramate selected to prevent the loss of effectiveness of phentermine alone. Methods for treating obesity, conditions associated with obesity, and other indications are also provided, as are compositions and dosage forms containing low doses of phentermine and topiramate, e.g., 3.75 mg phentermine and 23 mg topiramate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.